Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: November 29, 2009
Rituximab May Offer Hope To Severe Graves' Eye Disease Patients
November 29, 2009There may be hope for patients with severe Graves' eye disease in the form of treatment with the drug rituximab.
This news comes from U-M Kellogg Eye Center who's oculoplastics specialist Raymond S. Douglas, M.D., Ph.D. reports on the potential of the drug in the online October issue of Ophthalmology.
Graves' eye disease is an autoimmune disease that causes inflammation and fatty deposits in the eye muscles and connective tissue surrounding the eye.
Douglas reports on the progress of six patients (four women, two men) who had not responded to treatment using systemic corticosteroids. The patients were then treated with rituximab. All patients responded within 2 months with the clinical activity score (CAS) improving from5.5±0.8 to 1.3±0.5. The eye disease remained quiescent in all with the positive results being sustained at 4-6 months after treatment.
Vision improved bilaterally in all 4 patients with dysthyroid optic neuropathy (DON). Proptosis remained stable (Hertel measurement, 24±3.7 mm before therapy and 23.6±3.7 mm after therapy; P = 0.17).
"These patients had already received the maximum level of steroid treatment," says Douglas. "Treatment with rituximab calmed inflammation, stopped progression of the disease, and saved the patients from having to undergo surgery."
Graves' disease (also known as thyroid eye disease) is an autoimmune condition in which white blood cells attack the thyroid gland which responds by secreting an excess amount of thyroid hormone. The hypermetabolic state is characterized by fast pulse/heartbeat, palpitations, profuse sweating, high blood pressure, irritability, fatigue, weight loss, heat intolerance, and loss of hair and alterations in hair quality.
Rituximab has been used to treat patients with other autoimmune diseases, including rheumatoid arthritis and in non-Hodgkin's B-cell lymphoma. The drug works by depleting B cells - the body's normal antibody-producing cells - that appear to go awry in autoimmune diseases.
"Treatment of the inflammatory component of Graves' eye disease has not advanced appreciably over several decades," says Douglas. High-dose steroids, sometimes in combination with orbital radiation, are still the first line treatment. But, says Douglas, "These are imperfect options because inflammation often recurs when the treatment ends." He is hopeful that rituximab can offer sustained improvement. Douglas observes that the results from a small case series must be viewed with some caution. But given the substantial benefits for patients treated with rituximab, he sees good reason to proceed with a large-scale clinical trial to test this promising new drug.
Source
Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy; Ophthalmology, 2009; Chong et al.; DOI: 10.1016/j.ophtha.2009.05.029
University of Michigan Health System Newsroom
Archive issues: (50)
Archive list: 1 2 3 [4] 5 6 7 8 9 10 11 12 13 14 15 16 17
December 5, 2009 | Half of teen girls have STIs by 2 years of first sexWithin 2 years of having sex for the first time, half of teenage girls may be at least one of three common sexually transmitted infections (STIs), according to results of a study published today. Often, those girls are infected by the age of 15. Researchers followed 386 urban adolescent girls aged 14 to 17 for up to 8 years. Within 2 years of becoming sexually active, half of the girls ...
December 4, 2009 | Antidepressants May Change Your PersonalityTaking antidepressants may not only help alleviate depression, but could make you more extraverted and less neurotic, new research suggests. Extraversion, which is associated with positive emotions, is believed to help protect from depression, while neuroticism, the tendency to experience ...
December 3, 2009 | Smoking Exposure Now Linked to Colon, Breast CancersAdd colorectal cancer to the list of malignancies caused by smoking, with a new study strengthening the link between the two. And other studies are providing more bad news for people who haven't managed to quit: Two papers published in the ...
Related articles:
Stoicism and emotional repression
Society has different rules with regards to the way that men and women are supposed to express themselves. Men are generally regarded as the ones who are supposed to give comfort and strength. If they break down, cry, or seek comfort they may lose face. Women and other men do not give men an option to express feeling sad, tired, weak, depressed, inadequate, needy, or lonely without sacrificing their masculinity. Men are also four times more likely to commit suicide than women. Often, the ...Section: Mens health risks
Risk-taking
Men, significantly more so than women, tend to drink and drive, not to wear a seat belt, to be aggressive and fight, to drive fast and dangerously. Men are also more likely to be involved in a homicide, to be involved in a motor vehicle accident and other accidents. Men are in fact three times more likely to die of accidents than females. Men make up 93% of workplace deaths. While many argue that this is because dangerous jobs like mining are dominated by men, others argue that at least part of the difference is due to masculine ...Section: Mens health risks
Overview and symptoms
Erectile dysfunction is characterized by the regular or repeated inability to obtain or maintain an erection. There are several ways that erectile dysfunction is analyzed: Obtaining full erections at some times, such as when asleep (when the mind and psychological issues, if any, ...Section: Erectile Dysfunction